AMPLICHIP CYP450 TEST 04591402190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2011-01-12 for AMPLICHIP CYP450 TEST 04591402190 manufactured by Roche Molecular Systems.

Event Text Entries

[1784333] The customer site in the united states reported that discrepant results were generated when a patient specimen was tested with the amplichip cyp450 test. The complaint states that the issue occurred after the repeat testing of the original sample. According to the customer, originally there was no indication of discrepant results, and the repeat test was done by accident; the customer was unaware they had previously tested the sample. The patient was not harmed as a result of these discrepant test results.
Patient Sequence No: 1, Text Type: D, B5


[8924020] Investigation into this issue is ongoing, and therefore, no conclusion can be made at this time. Currently roche is waiting for data analysis results. According to the complaint, discrepant results were observed upon retesting a sample, the original results were accepted. Final investigative conclusions will be submitted through a follow-up report. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[9183965] Result: unapproved use of device. Conclusion: off-label, unapproved or contraindicated use. During the course of the investigation, it was determined that the customer was performing multiple off-label procedures not specified in the product labeling that could result in sub-optimal performance of the amplichip cyp450 assay. The customer adds blue juice to their samples prior to amplification to visually see their sample in the amplification tray. This may alter the working master mix (mmx) concentration and introduce dye into the pcr reaction. Bromophenol blue or alcohol may interfere with the pcr reaction. The customer vortexes and quick spins their samples at each step of the assay. Enzymes should not be vortexed. The customer stores extracted genomic dna beyond the package insert claims, which are 2-8c for up to one week or frozen at -20c for up to one month with no more than three freeze-thaw cycles. The customer does not check the dna quality as described in the product labeling. Internal testing of retain kit (b)(4) generated valid and acceptable results for the controls and stock dna samples and no discrepant results were generated. No product or batch non-conformance was identified during the course of the investigation. The discrepancies observed by the customer were likely the result of workflow and handling issues. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2011-00003
MDR Report Key1959204
Report Source05
Date Received2011-01-12
Date of Report2010-12-13
Date of Event2010-12-13
Date Mfgr Received2010-12-13
Device Manufacturer Date2010-09-30
Date Added to Maude2012-05-08
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202S
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameAMPLICHIP CYP450 TEST
Generic NameDRUG METABOLIZING ENZYME GENOTYPING SYSTEMS
Product CodeNTI
Date Received2011-01-12
Catalog Number04591402190
Lot NumberN12803
Device Expiration Date2011-04-30
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE MOLECULAR SYSTEMS
Manufacturer Address1080 US HW 202S BRANCHBURG NJ 08876373 US 08876 3733


Patients

Patient NumberTreatmentOutcomeDate
10 2011-01-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.